Travis Parigi, CEO of LiquidFrameworks, is excited about the new doors that have been opened for his company. Courtesy of LiquidFrameworks

Travis Parigi has built his software within his own company for about 14 years. Now, he's in a position to further develop his product at a faster rate.

In January, LiquidFrameworks entered into a partnership with private equity firm, Luminate Capital. The new financial partner has opened doors for Parigi and LiquidFrameworks — including putting merger and acquisition activity on the table.

"I have historically written stuff from the ground up, and we're going to continue to do that, but we want to give our customers more than that," Parigi tells InnovationMap. "And I've never had the opportunity to go out and strategically target opportunities where it makes sense to compliment the product. And I think that's going to be a very exciting thing to do."

Parigi, founder and CEO, tells InnovationMap about how his company has transformed over the years — and especially over the past several months with its new financial backer.

InnovationMap: How did you get your start in software development?

Travis Parigi: I've been building software since I was a very young kid, actually. I started writing software for companies at a very early age and realized that I really, really enjoyed it. And so when I say young, I'm talking in grade school and high school. And I really found that it was rewarding and I enjoyed meeting the requirements that people gave me. From the very early days, I knew I wanted to start a software company, but I really wasn't sure exactly what it would do. I went to work in the consulting industry right after graduating from A&M University with a degree in computer science and engineering and was building software for variety of different companies that were their clients and started to get some exposure to the energy industry.

Then in the late 1990s, the company I was at was going through some financial struggles, and it became an opportune time for me to start my own consulting company building software for companies. One client I had was Schlumberger, and I really started seeing this similar business problem related to collecting data at the well site. The workers in the field were working with paper and Excel. I thought it was a great opportunity to move people out of manual and into the digital world.

IM: Now, over a decade later, what role do you feel LiquidFrameworks plays in the industry?

TP: We play a role of standardizing the datasets that our clients are working with as it relates to the quote to cash process. So, specifically around their pricing data and their catalog data. We're standardizing that data and we're getting it into form and a shape that allows them to easily keep it up to date and easily syndicated changes related to that data out to not only other offices and districts, but also field crew that may be occasionally connected to the network.

With that data, we can do all sorts of things that end up benefiting the customer — like using it to create field tickets, invoices, work orders, safety forms, quotes, and all sorts of transactions that really need to be based upon one homogenous set of data that standardize, that isn't floating around in various documents.

IM: Where does the artificial intelligence LiquidFrameworks has developed come into play?

TP: We're taking it one step further, and once they finished those transactions, they end up with not just the reference data as it relates to pricing, but also the transactional data, we can use that data to infer the best way to quote or price new services in the future that will position the company and the best possible place to win the deals that they're quoting and bidding against. We're using different types of artificial intelligence algorithms to do that.

Nowadays, companies like us have at our disposal tools in the AI world — specifically in the machine learning world — that we just didn't have when I started the company. Fourteen years ago when I started the business, cloud computing in 2005 was not nearly as ubiquitous as it is today. And it wasn't as widely accepted and it certainly wasn't as widely accepted as it is in the energy industry today.

IM: What kind of clients are you working with?

TP: We're targeting three different industries. The upstream oil and gas service provider market, the downstream service provider market, and the emergency response service provider market. On the upstream side, they are companies doing work at the well site, and in downstream, they are companies doing work at the refineries.

IM: As automation and cloud technology is being more adapted within oil and gas, what technologies are now on your radar?

TP: In the beginning, we spent a lot of time educating our potential customers about cloud computing and about technologies that we had available. And now that a lot of that is so well received, it just means that we don't necessarily have to focus on that anymore. We can focus really on what really brings ROI to the customers that implement our product.

I keep a keen watch on a lot of the different technologies that are emerging out there. Blockchain is certainly one of them that we're looking at. I think there's some interesting things that we might be able to do with that as it relates to price book management, which is complex and varied. It could be that blockchain could end up providing a nice mechanism for both parties to independently have pricing data verified.

We're always keeping an eye on and doing work in artificial intelligence, specifically around machine learning. I think there's always new interesting stuff taking place there outside. I would say those two technologies are something that we're pretty pretty keen on.

IM: How has the transition into private equity been with your new partner in Silicon Valley-based Luminate Capital?

TP: We had a financial partner prior to Luminate Capital called Houston Ventures. Our managing partner there was a guy named Chip Davis. He was fantastic, and he helped us grow the business for about seven years. Eventually, we got to a point where we had grown to a level where I felt like, in order to do some things we wanted to do, we needed to establish a new financial partner. Private equity made the most sense for us, and it's really allowing us to do some things that we couldn't do with venture.

Over the years, we built out a fairly extensive roadmap, and my development team has worked very hard and diligently to fulfill those items on the roadmap. But our customer base has really grown significantly, and we've moved up into enterprise customers who have asked for a lot of things that we want to put into our product. And so our long range roadmap has grown. For these new features, we either need to build that ourselves in house, but, in some cases, there are some things that are tangential and complimentary to our product that other companies have already. So, it could make sense for us to go out and acquire those kinds of companies. And with Luminate, they provided us not only capital for us to do that, but equally as important, they provided an engine that we can facilitate from an M&A perspective to help us go and source those deals, find them, help assess them, and ultimately help acquire them and then integrate them into the overall platform.

IM: How has the partnership benefitted your company from a networking and opportunities perspective?

TP: Their portfolio of companies are similar to us and that they're are all enterprise software companies. They're not necessarily in the energy space, but they're all enterprise software companies. Being able to network with those companies has really been helpful. We didn't have a CFO prior to Luminate coming in. Part of the deal was that they said, "hey, we really would encourage and recommend that you get a CFO at this stage because you're growing and you need it." They provided some relationships there to in the form of recruiters to help us source the CFO. And we ended up sourcing a local CFO — Paul Marvin — who's absolutely fantastic.

IM: How has Houston been as a home base for you?

TP: Houston has been fantastic for LiquidFrameworks. I started the business based here and see no reason to change that. It is a fantastic market for us, both from a customer perspective as well as an employee perspective. The employee talent base in Houston is rich and deep. There's a lot of technical people here, and obviously there's a ton of energy companies.

IM: With all your operations being in Houston, do you see opportunities for other offices in the future?

TP: We have customers all over the world — a lot in Canada, so I could see an office there for sales and implementation. I would say that as we grow, expanding sales to other geographies is certainly something that will ultimately end up doing. It's just not something we've had to do yet.

IM: Are you planning on growing operations here?

TP: We've added a couple dozen people to the team just over the past few months, and we plan on doubling the staff by the end of next year.

------

Portions of this interview have been edited.

Houston-based LiquidFrameworks has been acquired by San Francisco-based Luminate Capital. Pexels

Houston startup exits to Bay Area private equity firm

Grand exit

A Houston startup has entered a deal with a San Francisco-based private equity firm, the companies announced on January 10. LiquidFrameworks, which provides cloud-based, mobile field operations management solutions to oil and gas, environmental, and industrial service companies, is now operating under Luminate Capital following the acquisition.

While not all the terms of the deal have been disclosed, Chip Davis, managing partner at Houston Ventures, says the transaction exceeded $50 million of PE investment from Luminate Capital. HV has been involved with LiquidFrameworks since 2012 and has invested a cumulative $6 million, Davis says, and brought in the company's current CEO and head of sales — both of who are still a part of the company's team.

"When we got involved, it was a very small company," says Davis. "As of today, it has enterprise customers of some of the largest oilfield services companies in the world."

According to the release, Hollie Haynes, Mark Pierce, and Sanjay Palakshappa from Luminate have joined the LiquidFrameworks board of directors. The PE fund's investment is a part of the recently closed $425 million Fund II.

"For over a decade, we have served field services companies by reducing revenue leakage, shortening cash collection cycles, and increasing overall operational efficiencies. We have streamlined the day-to-day operations for field services professionals and increased transparency across organizations by transforming previously paper- or excel-based workflows," says Travis Parigi, founder and COO of LiquidFrameworks, in the release.

"With a partner like Luminate Capital, we will continue to invest and develop product capabilities to better serve field services industries that have previously been overlooked by software innovation."

One of LiquidFrameworks' tools is FieldFX, which enhances companies' data accuracy and accelerates revenue capture and cash flow.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

New 'living pharmacy' biotech company launches out of Rice venture studio

fighting cancer

Rice University’s biotech venture studio RBL LLC has launched a new “living pharmacy” company, Duracyte, designed to make cancer treatment easier on patients.

Backed by an up to $45 million Advanced Research Projects Agency for Health (ARPA-H) award, Duracyte aims to commercialize implantable biohybrid pharmacy devices that are designed to produce therapeutic proteins inside the human body around the clock, replacing the need for regular injections and infusions for some cancer patients.

The company’s main platform is its Hybrid Advanced Molecular Manufacturing Regulator (HAMMR), a rechargeable, implantable device that can sense biological signals, monitor tumor environments and adjust therapeutic output in real time. HAMMR has wireless communication capabilities, which allow patients and clinicians to remotely monitor results through an app every five minutes and make changes to treatment plans without a hosptial visit. Additionally, the device can generate its own oxygen supply, which is key for the therapeutic cells’ survival.

“Biologic medicines such as monoclonal antibodies, cytokines and metabolic regulators already account for a significant share of modern therapeutics, but the way we deliver them today often requires frequent injections or infusions that can be demanding for patients and lead to inconsistent drug levels,” Daniel Anderson, MIT professor and co-founder of Duracyte, said in a news release. “Our vision is to enable a continuous, stable therapy by producing these medicines directly inside the body, which could improve treatment consistency, reduce side effects and ultimately transform how biologic therapies are delivered across many diseases.”

Duracyte’s first clinical trial is slated to begin by the end of 2026 and will focus on recurrent ovarian cancer. The Phase I study will build upon existing work on encapsulated cytokine pharmacy technology, and the company hopes that within a few years this treatment can reach clinical application.

The development of Duracyte is supported by ARPA-H's Targeted Hybrid Oncotherapeutic Regulation (THOR) project, which supports a multidisciplinary research consortium co-led by Omid Veiseh, a professor of bioengineering at Rice. The consortium also includes others at Rice, The University of Texas MD Anderson Cancer Center, Stanford University, Carnegie Mellon University, Northwestern University and the University of Houston, plus industry collaborators like Chicago-based CellTrans.

“What we are building is the culmination of years of progress in cell engineering, biomaterials and implantable device technology,” Veiseh added in the release. “By combining these advances with real-time sensing and adaptive drug delivery, we are working with the support of RBL to create a true ‘living pharmacy’ that can deliver continuous, precisely controlled biologic therapies and fundamentally change how these treatments reach patients.”

RBL launched in 2024 and is based out of Houston’s Texas Medical Center Helix Park. Duracyte is the third company launched by RBL, including Sentinel BioTherapeutics, a clinical-stage immunotherapy company developing localized cytokine therapies for solid tumors, and SteerBio, a regenerative medicine company targeting lymphedema.

“Duracyte exemplifies the kind of breakthrough that Houston’s ecosystem is built to produce,” Paul Wotton, managing partner of RBL LLC and co-founder of Duracyte, added in the release. “With world-class clinical infrastructure, exceptional engineering talent and initiatives like the Texas Biotech Task Force driving alignment across industry, investment and talent, this region is uniquely positioned to move the most ambitious ideas in medicine from concept to patient, faster than anywhere else.”

Houston energy hub opens new fundraising cohort to fuel startups

Apply Now

EnergyTech Cypher has opened applications for its second Liftoff fundraising program.

Applications close May 20 for the 10-week virtual fundraising sprint. The program is geared toward energy and climatech founders preparing to raise their first institutional round. It will cover fundraising requisites, like pitch materials, term sheet negotiation and round closing, according to a release from EnergyTech Cypher.

The program kicks off June 1 and runs every Monday from 1-3 p.m. CST. It will conclude with an in-person capstone simulation in Houston on August 3, where founders will work to close a mock round.

Jason Ethier, EnergyTech Cypher founder and CEO, will lead the program with Payal Patel, an EnergyTech fellow and entrepreneur in residence.

The program is available through Cephyron, EnergyTech Cypher's new investor relationship management platform, built specifically for energy and climatech founders. Users must have a Cephyron Boost membership to participate in the Liftoff program.

The Cephyron IRM app recently went live and is available to founders at any point in their fundraising process, according to the news release. The platform aggregates investor data, tracks market signals and delivers curated weekly recommendations.

EnergyTech Cypher launched Liftoff last year. The inaugural cohort included 19 startups, including Houston-based AtmoSpark Technologies, The Woodlands-based Resollant and others. Each participant closed at least one fundraising deal, according to EnergyTech Cypher.

EnergyTech Cypher rebranded from EnergyTech Nexus earlier this year. It also launched its CoPilot accelerator in 2025. The inaugural group presented its first showcase during CERAWeek last month.

EnergyTech Cypher's annual Pilotathon Pilot Pitch and Showcase applications also opened this month. Find more information here.

---

This article originally appeared on EnergyCaptialHTX.com.

Cancer diagnostics startup wins top prize at annual Rice competition​

winner, winners

Rice University student-founded companies took home a total of $115,000 in equity-free funding at the annual Liu Idea Lab for Innovation and Entrepreneurship's H. Albert Napier Rice Launch Challenge last week.

2025 Rice Innovation Fellow Alexandria Carter won the top prize and $50,000 for her startup Bionostic. The startup offers personalized diagnostics for cancer patients by using 3D culturing through its Advanced Tumor Landscape Analysis System (ATLAS) platform.

Carter is working toward her PhD in bioengineering in Professor Michael King's laboratory. She recently completed the Rice Innovation Fellows program and plans to commercialize ATLAS, according to a news release from Rice.

Actile Technologies, founded by another former Rice Innovation Fellow, Barclay Jumet, won second place and $25,000. The company is developing and commercializing textile-integrated technologies. InnovationMap first covered Jumet's wearable technology back in 2023.

Kairos took home the third-place prize and $15,000, plus the $2,000 audience choice award and the $5,000 undergraduate business award. Founded last year by Sanjana Kavula and Adhira Tippur, Kairos is an AI-powered patient intake platform built specifically for independent dental practices.

The NRLC features top startups founded by undergraduate, graduate and MBA students at Rice each year. The top three finishers were named among a group of five finalists earlier this year, which also included HAAST Autonomous and Project Kestrel.

HAAST is developing an unmanned aircraft for organ transport, while Kestrel uses machine learning to organize bird photographers’ photo collections.

Teams presented multiple five-minute pitches throughout the application process over Zoom and in-person before the five finalists presented at the NRLC Championships April 21 at the Rice Memorial Center. Each finalist walked away with an equity-free investment.


Other awards went to:

UnitCode

  • $5,000 MBA Venture Award

HAAST Autonomous

  • $2,500 Chan-Kang Family Prize for Bold Ambition
  • $1,000 Healthcare Innovations Prize

Telstar Networks

  • $2,500 Outstanding Undergraduate Startup Award

Multiplay

  • $1,500 Frank Liu Jr. Prize for Creative Innovation in Music, Fashion, & the Arts

Butterfly Books

  • $1,500 Social Impact Award

SOOZ

  • $1,000 Interdisciplinary Innovation Prize sponsored by OURI

Dooly

  • $1,000 Consumer Goods Prize

Project Kestrel

  • $1,000 AI Prize

Veloci Running won the NRLC last year for its naturally shaped running shoe. Founder and CEO Tyler Strothman recently told InnovationMap that the company has gone on to sell roughly 10,000 pairs of its flagship Ascent shoe, designed to relieve lower leg tightness and absorb impact. Read more here.